Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants

Virus-Specific Antibody, Viral Load, and Disease Severity in Respiratory Syncytial Virus Infection

(2018) Edward E Walsh et al.   JOURNAL OF INFECTIOUS DISEASES

The interdependencies of viral load, the innate immune response, and clinical outcome in children presenting to the emergency department with respiratory syncytial virus-associated bronchiolitis

(2017) Felipe-Andrés Piedra et al.   PLoS One

A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants

(2017) Qing Zhu et al.   Science Translational Medicine

A Phase 2 randomized, observer-blind, placebo-controlled, dose-ranging trial of aluminum-adjuvanted respiratory syncytial virus F particle vaccine formulations in healthy women of childbearing age

(2017) Allison August et al.   VACCINE

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein

(2017) Jarrod J. Mousa et al.   Nature Microbiology

Effectiveness of Prenatal Versus Postpartum Tetanus, Diphtheria, and Acellular Pertussis Vaccination in Preventing Infant Pertussis

(2016) Kathleen Winter et al.   CLINICAL INFECTIOUS DISEASES

Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis

(2016) Christiane S. Eberhardt et al.   CLINICAL INFECTIOUS DISEASES

WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015

(2016) Kayvon Modjarrad et al.   VACCINE

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

(2015) Patricio L. Acosta et al.   Clinical and Vaccine Immunology

A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age

(2015) Gregory M. Glenn et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

(2015) Katherine L O'Brien et al.   LANCET INFECTIOUS DISEASES

Key terms for the assessment of the safety of vaccines in pregnancy: Results of a global consultative process to initiate harmonization of adverse event definitions

(2015) Flor M. Munoz et al.   VACCINE

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

(2015) Anders Krarup et al.   Nature Communications

Respiratory Syncytial Virus Transplacental Antibody Transfer and Kinetics in Mother-Infant Pairs in Bangladesh

(2014) Helen Y. Chu et al.   JOURNAL OF INFECTIOUS DISEASES

The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels – A prospective study

(2014) Bahaa Abu Raya et al.   VACCINE

An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization

(2014) Rama Raghunandan et al.   VACCINE

Interventions to reduce neonatal mortality from neonatal tetanus in low and middle income countries - a systematic review

(2013) Adeel Ahmed Khan et al.   BMC PUBLIC HEALTH

Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants

(2013) Maarten O. Blanken et al.   NEW ENGLAND JOURNAL OF MEDICINE

Respiratory Syncytial Virus-Associated Hospitalizations Among Children Less Than 24 Months of Age

(2013) C. B. Hall et al.   PEDIATRICS

Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial

(2012) M. C. Steinhoff et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Risk of Adverse Fetal Outcomes Following Administration of a Pandemic Influenza A(H1N1) Vaccine During Pregnancy

(2012) Björn Pasternak et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats

(2012) Gale Smith et al.   PLoS One

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

(2012) Gregory M. Glenn et al.   VACCINE

Evidence for a causal relationship between respiratory syncytial virus infection and asthma

(2011) Pingsheng Wu et al.   Expert Review of Anti-Infective Therapy

Transplacental transport of IgG antibodies to preterm infants: A review of the literature

(2010) J.P. van den Berg et al.   EARLY HUMAN DEVELOPMENT

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

(2010) Harish Nair et al.   LANCET

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effectiveness of Maternal Influenza Immunization in Mothers and Infants

(2008) K. Zaman et al.   NEW ENGLAND JOURNAL OF MEDICINE